Shelf Life Boost For ProteqFlu - From 27 To 36 Months

ProteqFlu, the first and only live attenuated canarypox equine influenza (EI) vaccine, has had its shelf life extended from 27 to 36 months. The move is the result of on-going investment in vaccine research & development, and the new data underpins the stability of this modified live vaccine technology’ says manufacturer, Merial. ProteqFlu is the only equine flu vaccine in Europe to include the updated American clade 1 Ohio/03 strain in accordance with the OIE recommendations (2004).

More from

• West Midlands communications agency celebrates quartet of award nominations for work in veterinary sector
• IVC Evidensia assembles expert team to run new £10m referral hospital
• Home delivery service can increase pet health plan sign-ups by 25%
• Research reveals vital clues to help fight anthelmintic resistance
• Lifetime Achievement Award recognises Harrogate vet’s dedication to improving the health and welfare of rabbits